178 related articles for article (PubMed ID: 26690494)
21. [A retrospective study of the impact of diabetes mellitus on survival in patients with lung cancer].
Han R; Yang G; Lyu Z; Gu W; Du J; Jin N; Zang L; Yang L; Guo Q; Ba J; Dou J; Mu Y
Zhonghua Nei Ke Za Zhi; 2015 Dec; 54(12):1028-31. PubMed ID: 26887369
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with advanced non-small cell lung cancer: single center experience.
Inal A; Kucukoner M; Kaplan MA; Urakci Z; Karakus A; Komek H; Dostbil Z; Isikdogan A
J BUON; 2012; 17(4):724-8. PubMed ID: 23335532
[TBL] [Abstract][Full Text] [Related]
23. [Prognostic factors in unresectable lung cancer].
Urata A
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2035-42. PubMed ID: 2840034
[TBL] [Abstract][Full Text] [Related]
24. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
[TBL] [Abstract][Full Text] [Related]
25. Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib.
Fiala O; Pesek M; Finek J; Topolcan O; Racek J; Svaton M; Kucera R; Minarik M; Benesova L; Bortlicek Z; Chloupkova R; Poprach A; Buchler T
Anticancer Res; 2016 May; 36(5):2459-65. PubMed ID: 27127158
[TBL] [Abstract][Full Text] [Related]
26. Effect of the BCL2 gene polymorphism on survival in advanced-stage non-small cell lung cancer patients who received chemotherapy.
Masago K; Togashi Y; Fujita S; Nagai H; Sakamori Y; Okuda C; Kim YH; Mishima M
Oncology; 2013; 84(4):214-8. PubMed ID: 23364242
[TBL] [Abstract][Full Text] [Related]
27. [Elevated serum NSE level in locally advanced and metastatic NSCLC predispose to better response to chemotherapy but worse survival].
Załeska M; Szturmowicz M; Zych J; Roszkowska-Sliz B; Demkow U; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2010; 78(1):14-20. PubMed ID: 20162514
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of serum sMICA levels in non-small cell lung cancer.
Wang LP; Niu H; Xia YF; Han YL; Niu P; Wang HY; Zhou QL
Eur Rev Med Pharmacol Sci; 2015 Jun; 19(12):2226-30. PubMed ID: 26166647
[TBL] [Abstract][Full Text] [Related]
29. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
Ardizzoni A; Cafferata MA; Paganuzzi M; Filiberti R; Marroni P; Neri M; Fontana V; Nicoló G; Perdelli L; Stampino CG; Rosso R; Puntoni R
Cancer; 2001 Oct; 92(7):1896-904. PubMed ID: 11745263
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors in elderly patients with unresectable non-small cell lung cancer.
Kimura T; Kudoh S; Hirata K; Takifuji N; Negoro S; Yoshikawa J
Anticancer Res; 2001; 21(2B):1379-83. PubMed ID: 11396218
[TBL] [Abstract][Full Text] [Related]
31. Clinical features and prognostic factors in patients with bone metastases from non-small cell lung cancer.
Wu XT; Zhou JW; Pan LC; Ge T
J Int Med Res; 2020 May; 48(5):300060520925644. PubMed ID: 32425092
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of the baseline serum uric acid level in non-small cell lung cancer patients treated with first-line chemotherapy: a study of the Turkish Descriptive Oncological Researches Group.
Tanriverdi O; Cokmert S; Oktay E; Pilanci KN; Menekse S; Kocar M; Sen CA; Avci N; Akman T; Ordu C; Goksel G; Meydan N
Med Oncol; 2014 Oct; 31(10):217. PubMed ID: 25216865
[TBL] [Abstract][Full Text] [Related]
33. Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort.
Sun H; Hu P; Shen H; Dong W; Zhang T; Liu Q; Du J
PLoS One; 2015; 10(12):e0144663. PubMed ID: 26656866
[TBL] [Abstract][Full Text] [Related]
34. Pretreatment Pokemon Level as a Predictor of Response to Cisplatin and Paclitaxel in Patients with Unresectable Non-Small Cell Lung Cancer.
Zhang QL; Xing XZ; Li FY; Xing YJ; Li J
Oncol Res Treat; 2015; 38(10):496-502. PubMed ID: 26451776
[TBL] [Abstract][Full Text] [Related]
35. The role of serum carcinoembryonic antigen in predicting responses to chemotherapy and survival in patients with non-small cell lung cancer.
Liu H; Gu X; Lv T; Wu Y; Xiao Y; Yuan D; Li Y; Song Y
J Cancer Res Ther; 2014; 10(2):239-43. PubMed ID: 25022372
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of weight gain during definitive chemoradiotherapy for locally advanced non-small-cell lung cancer.
Sher DJ; Gielda BT; Liptay MJ; Warren WH; Batus M; Fidler MJ; Garg S; Bonomi P
Clin Lung Cancer; 2013 Jul; 14(4):370-5. PubMed ID: 23260389
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.
Kim HC; Song JS; Lee JC; Lee DH; Kim SW; Lee JS; Kim WS; Rho JK; Kim SY; Choi CM
Int J Clin Exp Pathol; 2014; 7(10):6743-51. PubMed ID: 25400754
[TBL] [Abstract][Full Text] [Related]
38. Serum levels of the cancer-testis antigen POTEE and its clinical significance in non-small-cell lung cancer.
Wang Q; Li X; Ren S; Cheng N; Zhao M; Zhang Y; Li J; Cai W; Zhao C; Cao W; Zhou C
PLoS One; 2015; 10(4):e0122792. PubMed ID: 25860145
[TBL] [Abstract][Full Text] [Related]
39. Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer.
Omar M; Tanriverdi O; Cokmert S; Oktay E; Yersal O; Pilancı KN; Menekse S; Kocar M; Sen CA; Ordu C; Goksel G; Meydan N; Barutca S;
Clin Respir J; 2018 Mar; 12(3):922-929. PubMed ID: 28026133
[TBL] [Abstract][Full Text] [Related]
40. Fasting blood glucose level and prognosis in non-small cell lung cancer (NSCLC) patients.
Luo J; Chen YJ; Chang LJ
Lung Cancer; 2012 May; 76(2):242-7. PubMed ID: 22112292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
